Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5125)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2015 (publication date) through May 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takenaka T, Inoue T, Watanabe Y. How the kidney hyperfiltrates in diabetes: From molecules to hemodynamics. World J Diabetes 2015; 6(4): 576-582 [PMID: 25987955 DOI: 10.4239/wjd.v6.i4.576] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v6/i4/576.htm |
| Number | Citing Articles |
| 1 |
Habib Yaribeygi, Thozhukat Sathyapalan, Mina Maleki, Tannaz Jamialahmadi, Amirhossein Sahebkar. Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review. Life Sciences 2020; 240: 117090 doi: 10.1016/j.lfs.2019.117090
|
| 2 |
Yang Yang, Gaosi Xu. Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.872918
|
| 3 |
Liwen Bao, Xiufang Gao, Kun Xie, Yong Li. Is There a Diabetes–Kidney–Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.716083
|
| 4 |
Habib Yaribeygi, Alexandra E. Butler, Stephen L. Atkin, Niki Katsiki, Amirhossein Sahebkar. Sodium–glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways. Journal of Cellular Physiology 2019; 234(1): 223 doi: 10.1002/jcp.26851
|
| 5 |
A. N. Kulikov, O. N. Beresneva, M. M. Parastaeva, S. V. Okovityi, G. T. Ivanova, D. Yu. Ivkin, A. S. Ivkina, E. N. Levykina, M. I. Zaraiskii, A. A. Karpov, A. G. Kucher, I. M. Zubina, O. V. Galkina, I. G. Kaiukov. INFLUENCE OF EMPAGLIFLOZIN ON THE KIDNEYS IN NORMOGLYCEMIC RATS WITH HEART FAILURE. Nephrology (Saint-Petersburg) 2017; 21(2): 83 doi: 10.24884/1561-6274-2017-21-2-83-92
|
| 6 |
Ping Hu, Xiang-Hai Zhou, Xin Wen, Linong Ji. Predictors of Renal Function Decline in Chinese Patients with Type 2 Diabetes Mellitus and in a Subgroup of Normoalbuminuria: A Retrospective Cohort Study. Diabetes Technology & Therapeutics 2016; 18(10): 635 doi: 10.1089/dia.2016.0115
|
| 7 |
Eun Sil Koh, Gheun-Ho Kim, Sungjin Chung. Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis. Endocrinology and Metabolism 2023; 38(4): 359 doi: 10.3803/EnM.2023.1764
|